These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 25124606

  • 1. Emodin inhibits breast cancer cell proliferation through the ERα-MAPK/Akt-cyclin D1/Bcl-2 signaling pathway.
    Sui JQ, Xie KP, Zou W, Xie MJ.
    Asian Pac J Cancer Prev; 2014; 15(15):6247-51. PubMed ID: 25124606
    [Abstract] [Full Text] [Related]

  • 2. Annonacin induces cell cycle-dependent growth arrest and apoptosis in estrogen receptor-α-related pathways in MCF-7 cells.
    Ko YM, Wu TY, Wu YC, Chang FR, Guh JY, Chuang LY.
    J Ethnopharmacol; 2011 Oct 11; 137(3):1283-90. PubMed ID: 21840388
    [Abstract] [Full Text] [Related]

  • 3. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
    Ye X, Yuan L, Zhang L, Zhao J, Zhang CM, Deng HY.
    Asian Pac J Cancer Prev; 2014 Oct 11; 15(12):5001-7. PubMed ID: 24998578
    [Abstract] [Full Text] [Related]

  • 4. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 11; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between the inhibitory effect of fraxetin on breast cancer and estrogen signaling pathway].
    Huo HN, Xie KP, Wang LM, Jiang Y, Zou W, Xie MJ.
    Sheng Li Xue Bao; 2013 Jun 25; 65(3):323-8. PubMed ID: 23788190
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T, Gomes A.
    Chem Biol Interact; 2017 Apr 25; 268():119-128. PubMed ID: 28322778
    [Abstract] [Full Text] [Related]

  • 11. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y, Zhang Y, Liu C, Zhang J, Smith WW, Wang N, Chen Y, Zheng L, He L.
    Cancer Prev Res (Phila); 2012 Jun 25; 5(6):864-73. PubMed ID: 22496388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways.
    Wu K, Wang C, D'Amico M, Lee RJ, Albanese C, Pestell RG, Mani S.
    Mol Cancer Ther; 2002 Jul 25; 1(9):695-706. PubMed ID: 12479366
    [Abstract] [Full Text] [Related]

  • 14. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
    Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N, Damodaran C.
    Int J Cancer; 2009 Aug 15; 125(4):961-7. PubMed ID: 19384950
    [Abstract] [Full Text] [Related]

  • 15. Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling.
    Tohkayomatee R, Reabroi S, Tungmunnithum D, Parichatikanond W, Pinthong D.
    Molecules; 2022 May 31; 27(11):. PubMed ID: 35684480
    [Abstract] [Full Text] [Related]

  • 16. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
    Chewchuk S, Guo B, Parissenti AM.
    PLoS One; 2017 May 31; 12(2):e0172244. PubMed ID: 28196134
    [Abstract] [Full Text] [Related]

  • 17. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
    Lin Z, Zhang X, Zhao F, Ru S.
    Toxicol Appl Pharmacol; 2019 Mar 01; 366():75-82. PubMed ID: 30684532
    [Abstract] [Full Text] [Related]

  • 18. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival.
    Bratton MR, Duong BN, Elliott S, Weldon CB, Beckman BS, McLachlan JA, Burow ME.
    Int J Oncol; 2010 Sep 01; 37(3):541-50. PubMed ID: 20664923
    [Abstract] [Full Text] [Related]

  • 19. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J, Zeng J, Xin M, Huang W, Chen X.
    Horm Metab Res; 2011 Sep 01; 43(10):681-6. PubMed ID: 21932171
    [Abstract] [Full Text] [Related]

  • 20. Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells.
    Zhang X, Deng H, Wang ZY.
    J Steroid Biochem Mol Biol; 2014 Sep 01; 143():434-43. PubMed ID: 24973581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.